News

Understanding SelectQuote, Inc. Class Action Lawsuits

Understanding SelectQuote, Inc. Class Action Lawsuits

Class Action Lawsuit Overview

Robbins LLP is reaching out to investors regarding a significant class action lawsuit connected to SelectQuote, Inc. (NYSE: SLQT). The lawsuit concerns stockholders who acquired SelectQuote shares within a specific time frame. SelectQuote is known as a digital insurance broker that specializes in helping individuals enroll in Medicare Advantage and other health insurance plans through online services and over-the-phone assistance.

The Core Allegations

Claims of Misleading Practices

The allegations posited in the lawsuit stem from claims that during the designated class period, SelectQuote failed to provide transparent information regarding its services. The core issues raised include:

1. Misleading direction towards plans from insurers that offered the highest compensation to SelectQuote, neglecting the quality of the plans.

2. Lack of unbiased comparisons in Medicare Advantage plans, which misled customers regarding their options.

3. Receiving illegal payments, referred to as kickbacks, from insurers in exchange for steering clients exclusively towards particular plans, while limiting access to competitive options.

4. Inherent vulnerabilities leading to potential sanctions due to these practices, which are claims of violating the False Claims Act.

The Impact of DOJ Involvement

On May 1, 2025, the U.S. Department of Justice took substantial action by filing a False Claims Act complaint against SelectQuote. The complaint highlighted that from 2016 to at least 2021, SelectQuote accrued millions in illegal kickbacks from health insurance companies. This scheme allegedly involved steering beneficiaries towards plans that would benefit the companies rather than considering the best interests of the clients themselves.

Consequences of the Allegations

As these serious allegations came to light, the repercussions were immediate and reflected in the stock market. SelectQuote's stock price encountered a significant drop, illustrating the sensitivity of investor confidence associated with claims of corporate malfeasance. Specifically, the stock price fell by nearly 19.2% on the announcement day, underscoring the impact that such litigation can have on a company's market valuation.

What Should Investors Do Next?

Participation in the Class Action

Current and former shareholders who purchased SelectQuote stock during the class period may be eligible to participate in this class action lawsuit. Investors seeking to take on the role of lead plaintiff—representing the interests of shareholders in directing the litigation—should contact Robbins LLP to explore their options. It is crucial to note that engaging as a lead plaintiff does not require one to actively participate in the case; shareholders may choose to remain passive members of the class.

Robbins LLP: Representing Shareholder Rights

Robbins LLP has established itself as a key player in shareholder rights litigation since its inception in 2002. The firm has committed itself to enabling shareholders to recover losses while enhancing corporate governance and accountability among executives. If you have suffered due to the recent developments regarding SelectQuote, reaching out to Robbins LLP may provide essential support.

Company Contact Information

For further inquiries, shareholders may contact:

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
Phone: (800) 350-6003

Frequently Asked Questions

What is the focus of the SelectQuote class action lawsuit?

The class action lawsuit targets misleading practices allegedly employed by SelectQuote, including steering customers toward specific insurance plans based on kickbacks.

Who can participate in the class action?

Any shareholders who acquired SelectQuote, Inc. (NYSE: SLQT) between the defined period are eligible to participate in the class action.

What are the potential outcomes for investors?

Investors may be entitled to recover losses depending on the case's outcome, which aims to address the alleged violations and restore trust in shareholder rights.

What does being a lead plaintiff entail?

A lead plaintiff represents the class in legal matters, guiding the lawsuit while not requiring them to engage in active litigation if they choose not to.

How can I contact Robbins LLP?

Shareholders can reach Robbins LLP at (800) 350-6003 or contact attorney Aaron Dumas, Jr. via email or phone for assistance regarding the class action.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 392

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 139

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 255

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 253

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 204

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
LaserAway Expands to 244 Clinics Over 20 Years

Updated Category News Views 203

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Continue Reading
Layne's Chicken Fingers Expands with Brownsville Opening

Updated Category News Views 200

Fried Delights Rise in Brownsville Never thought I'd see the day when chicken fingers felt like the main character in an epic expansion saga, but here we are. Ricki Oberoi, a veteran in the fast-food game, is pushing onward with Layne's Chicken Fingers in Brownsville, Texas. I tell you, some folks are as keen on expanding their palates as they are their portfolios....

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 166

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading

Top 5 Most Recently Viewed Articles

AngioDynamics' NanoKnife® System Receives FDA Clearance

Updated Category News Views 191

Introduction to AngioDynamics' Innovation AngioDynamics, Inc. (NASDAQ: ANGO), a forward-thinking medical technology firm, has made significant strides in restoring healthy blood flow and enhancing cancer treatment options. Recently, the company announced its accomplishment in receiving FDA 510(k) clearance for its advanced NanoKnife System, specifically designed for...

Continue Reading
Analyst Predicts iPhone Dominance in Apple's Future Revenues

Updated Category News Views 197

Apple's Revenue Outlook and iPhone Influence A recent analysis by Needham paints a promising picture for Apple Inc (NASDAQ: AAPL) as the company prepares for fiscal year 2025. Analyst Laura Martin affirmed a buy rating for Apple, setting an impressive price target of $260. This forecast is based on a well-crafted Discounted Cash Flow (DCF) model, which includes a cash tax...

Continue Reading
Sitetracker's Record Growth and Vision for Future Success

Updated Category News Views 398

Remarkable Achievements in 2024 for Sitetracker Sitetracker has reached significant milestones marking the close of its fiscal year with outstanding growth and exciting plans for the upcoming year. As a leader in the field of asset lifecycle management, they have positioned themselves strongly in markets worldwide, focusing on providing tools for various critical...

Continue Reading
Olympus Showcases Innovative ENT Solutions at Major Meetings

Updated Category News Views 176

Olympus Highlights Cutting-Edge ENT Solutions Olympus Corporation of the Americas, a leading medical technology company committed to enhancing health and safety, will unveil its extensive ENT portfolio at upcoming annual physician meetings. Attendees will have the opportunity to see how Olympus integrates hybrid endoscopy with advanced imaging and content management...

Continue Reading
Exciting Launch of Tech Mahindra Chess League Season 3

Updated Category News Views 101

Tech Mahindra Global Chess League Season 3 Launches with Excitement The Global Chess League (GCL) has officially begun its Season 3, and excitement fills the air as six teams are set to compete in 34 matches for the coveted championship trophy. The league kicked off at Mumbai's Royal Opera House, a perfect venue for this grand event. Spectacular Opening Ceremony in Mumbai...

Continue Reading